Announcements Trials
Browse Landscape

Phase

Phase 4 6Phase 2 4Phase NA 2Phase EARLY_PHASE1 1

Status

Completed 3Not yet recruiting 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 3Thoracic 1

Conditions

Lymphoma, B-Cell, Marginal Zone 2Lymphoma, Non-Hodgkin 1Lymphoma 1Lung Neoplasms 1Exanthema 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Tetracycline × Clear all
NCT07144657 2025-08-27

GastricMALToma

National Taiwan University Hospital

Phase 2 Not yet recruiting
40 enrolled
Lymphoid

Lymphoma, B-Cell, Marginal Zone

NCT01880515 2025-05-11

Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)

Instituto Nacional de Cancerologia de Mexico

Phase 2 Completed
107 enrolled 8 charts
Thoracic

Exanthema, Lung Neoplasms

NCT00002682 2018-10-24

Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach

M.D. Anderson Cancer Center

Phase 2 Completed
5 enrolled
Lymphoid

Lymphoma, Lymphoma, B-Cell, Marginal Zone

NCT01010295 2013-11-25

IELSG27

International Extranodal Lymphoma Study Group (IELSG)

Phase 2 Completed
54 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡